SEELEY BRUCE J. 4
4 · CTI BIOPHARMA CORP · Filed Mar 13, 2020
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Non-qualified Stock Option
2020-03-11+330,000→ 330,000 totalExercise: $1.00Exp: 2030-03-11→ Common stock (330,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates. The stock option is also subject to stockholder approval of an increase in the share reserve under the 2017 Equity Incentive Plan of the Company, which approval must occur within one year from the grant date.